Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04386187
Other study ID # 180215
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 28, 2020
Est. completion date April 2, 2021

Study information

Verified date January 2022
Source University of California, San Diego
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research study is to find out whether certain plant-based foods may be beneficial for individuals with type 2 diabetes. To meet the goal, study participants will be fed known amounts of foods and nutrients. Before and after participants have eaten the food, they will self-measure height, weight, and waist circumference and study staff will administer questionnaires. Blood samples will be taken at a local lab to measure blood sugar and blood lipids.All study appointments will be conducted online.


Description:

This research study is a randomized, controlled trial that will evaluate whether diet and nutrition education on, and short-term partial feeding of, specific plant foods high in the antioxidant glutathione will impact total glutathione status, gamma-glutamyltransferase (GGT) activity, glucose control or insulin sensitivity in people with type 2 diabetes. Dietary education will include information on plant sources of glutathione, as well as, cooking methods to reduce glycation and lipid peroxidation during cooking, which may indirectly alter glutathione status by reduce demand for elimination of these compounds. Participants will be randomized to one of two groups: the educational intervention plus partial feeding of two small meals per day vs. a wait list control group that will receive standard advice on nutrition for diabetes. After 12 weeks, the intervention group will no longer receive foods, but will be followed for 12 additional weeks to determine if lasting effects are achieved. After 12 weeks, the control group will receive access to the educational materials, but will not receive study foods, to see if the educational intervention alone impacts food/nutrition choices. Both groups will have lab measures (as described above) again after this additional 12 weeks, for a total duration of 24 weeks in the trial.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date April 2, 2021
Est. primary completion date April 2, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Men and women - Ages 18 to 65 - Type 2 diabetes - Free of self-reported acute and confounding chronic diseases (e.g., heart failure, kidney disease, liver disease, gastrointestinal disorder) based on a standardized medical history questionnaire - Free of alcoholism, smoking and major cardiovascular event with the past 6 months - Not on insulin to help manage diabetes - Planning on staying in the San Diego area for the next 6 months - Willing to select plant-based foods from a "menu" and eat the selected foods provided by the study team - Have access to the internet and a computer - Willing to view 4 weekly educational classes online, followed by periodic telephone and email contacts - Agree to schedule and complete periodic questionnaires and measurements during up to four total online appointments Exclusion Criteria: - Alcoholism, smoking and recent cardiovascular events - Individuals will be excluded if they report any dietary restrictions, allergies or preferences - Unsuitability based on screening visit

Study Design


Intervention

Other:
GSH Foods
The intervention consists of customized foods/small meals that have been designed to be high in a single nutrient called glutathione (GSH).
Nutrition education about glutathione sources in the diet
Four videos will outline food sources of glutathione, cooking methods to reduce systemic requirements for glutathione, food sources of nutrient cofactors for glutathione production and other related content.
Standard of care nutrition education for type 2 diabetes
The educational control is provided with information on standard dietary interventions for diabetes as electronic handouts and web links.

Locations

Country Name City State
United States University of California, San Diego San Diego California

Sponsors (1)

Lead Sponsor Collaborator
University of California, San Diego

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Total glutathione Total glutathione concentration in the blood 24 weeks
Other gamma-glutamyltransferase (GGT) Measure of glutathione demand in the blood 24 weeks
Other Fasting insulin Plasma insulin concentration while fasting 24 weeks
Other Fasting glucose Serum glucose concentration while fasting 24 weeks
Other Hemoglobin A1c Measure of glycemic control 24 weeks
Other Homeostasis Assessment Index of Insulin Resistance (HOMA-IR) Estimate of insulin resistance 24 weeks
Other Low density lipoprotein concentration (LDL-c) concentration of LDL lipoproteins in serum 24 weeks
Other High density lipoprotein concentration (HDL) concentration of HDL lipoproteins in serum 24 weeks
Other Triglycerides concentration of triglycerides in serum 24 weeks
Primary Total glutathione Total glutathione concentration in the blood 12 weeks
Primary gamma-glutamyltransferase (GGT) Measure of glutathione demand in the blood 12 weeks
Secondary Fasting glucose Serum glucose concentration while fasting 12 weeks
Secondary Fasting insulin Plasma insulin concentration while fasting 12 weeks
Secondary Hemoglobin A1c Measure of glycemic control 12 weeks
Secondary Homeostasis Assessment Index of Insulin Resistance (HOMA-IR) Estimate of insulin resistance 12 weeks
Secondary Low density lipoprotein concentration (LDL-c) concentration of LDL lipoproteins in serum 12 weeks
Secondary High density lipoprotein concentration (HDL) concentration of HDL lipoproteins in serum 12 weeks
Secondary Triglycerides concentration of triglycerides in serum 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT05219994 - Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum N/A
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Completed NCT02284893 - Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone Phase 3
Completed NCT04274660 - Evaluation of Diabetes and WELLbeing Programme N/A
Active, not recruiting NCT05887817 - Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Phase 4
Active, not recruiting NCT05566847 - Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Completed NCT04965506 - A Study of IBI362 in Chinese Patients With Type 2 Diabetes Phase 2
Recruiting NCT06115265 - Ketogenic Diet and Diabetes Demonstration Project N/A
Active, not recruiting NCT03982381 - SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes Phase 4
Completed NCT04971317 - The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages N/A
Completed NCT04496154 - Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood N/A
Completed NCT04023539 - Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05530356 - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Completed NCT04097600 - A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets Phase 1
Completed NCT03960424 - Diabetes Management Program for Hispanic/Latino N/A
Completed NCT05378282 - Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
Active, not recruiting NCT06010004 - A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Phase 3
Completed NCT03653091 - Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes N/A